Published in J Invest Dermatol on October 18, 2007
Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis. Nat Genet (2009) 5.93
Epithelial antimicrobial defence of the skin and intestine. Nat Rev Immunol (2012) 3.21
Neuroendocrine nicotinic receptor activation increases susceptibility to bacterial infections by suppressing antimicrobial peptide production. Cell Host Microbe (2010) 2.39
Epidermal Notch1 loss promotes skin tumorigenesis by impacting the stromal microenvironment. Cancer Cell (2009) 2.19
Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms. J Allergy Clin Immunol (2008) 2.11
Global gene expression analysis reveals evidence for decreased lipid biosynthesis and increased innate immunity in uninvolved psoriatic skin. J Invest Dermatol (2009) 2.06
The skin barrier as an innate immune element. Semin Immunopathol (2007) 1.81
Skin-derived TSLP triggers progression from epidermal-barrier defects to asthma. PLoS Biol (2009) 1.76
Local burn injury impairs epithelial permeability and antimicrobial peptide barrier function in distal unburned skin. Crit Care Med (2014) 1.47
Abnormal skin barrier in the etiopathogenesis of atopic dermatitis. Curr Opin Allergy Clin Immunol (2009) 1.43
Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases. J Clin Invest (2012) 1.38
Regulation of cathelicidin antimicrobial peptide expression by an endoplasmic reticulum (ER) stress signaling, vitamin D receptor-independent pathway. J Biol Chem (2011) 1.20
TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes. J Invest Dermatol (2010) 1.18
Urea uptake enhances barrier function and antimicrobial defense in humans by regulating epidermal gene expression. J Invest Dermatol (2012) 1.10
Activation of epidermal toll-like receptor 2 enhances tight junction function: implications for atopic dermatitis and skin barrier repair. J Invest Dermatol (2012) 1.08
Ablation of the calcium-sensing receptor in keratinocytes impairs epidermal differentiation and barrier function. J Invest Dermatol (2012) 1.04
Matriptase-deficient mice exhibit ichthyotic skin with a selective shift in skin microbiota. J Invest Dermatol (2009) 1.01
Therapeutic Implications of a Barrier-based Pathogenesis of Atopic Dermatitis. Ann Dermatol (2010) 1.00
Protease and protease-activated receptor-2 signaling in the pathogenesis of atopic dermatitis. Yonsei Med J (2010) 0.99
Changes of antimicrobial peptides and transepidermal water loss after topical application of tacrolimus and ceramide-dominant emollient in patients with atopic dermatitis. J Korean Med Sci (2010) 0.98
Evidence that stress to the epidermal barrier influenced the development of pigmentation in humans. Pigment Cell Melanoma Res (2009) 0.96
Epidermal barrier defects link atopic dermatitis with altered skin cancer susceptibility. Elife (2014) 0.95
Ets1 blocks terminal differentiation of keratinocytes and induces expression of matrix metalloproteases and innate immune mediators. J Cell Sci (2010) 0.94
What Lives On Our Skin: Ecology, Genomics and Therapeutic Opportunities Of the Skin Microbiome. Drug Discov Today Dis Mech (2013) 0.93
The emerging role of peptides and lipids as antimicrobial epidermal barriers and modulators of local inflammation. Skin Pharmacol Physiol (2012) 0.93
A novel role of a lipid species, sphingosine-1-phosphate, in epithelial innate immunity. Mol Cell Biol (2012) 0.93
Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis. Clin Rev Allergy Immunol (2011) 0.91
Toll-like receptor 3 activation is required for normal skin barrier repair following UV damage. J Invest Dermatol (2014) 0.91
Expression of epidermal CAMP changes in parallel with permeability barrier status. J Invest Dermatol (2011) 0.90
A central theory of biology. Med Hypotheses (2015) 0.89
Protecting the boundary: the sentinel role of host defense peptides in the skin. Cell Mol Life Sci (2011) 0.89
The effect of adipose-derived stem cell-cultured media on oxazolone treated atopic dermatitis-like murine model. Ann Dermatol (2012) 0.89
Barrier requirements as the evolutionary "driver" of epidermal pigmentation in humans. Am J Hum Biol (2010) 0.89
Skin barrier function. Curr Allergy Asthma Rep (2008) 0.88
Modeling atopic dermatitis with increasingly complex mouse models. J Invest Dermatol (2008) 0.88
Epidermal permeability barrier defects and barrier repair therapy in atopic dermatitis. Allergy Asthma Immunol Res (2014) 0.88
Stratum corneum dysfunction in dandruff. Int J Cosmet Sci (2012) 0.88
Cellular basis of secondary infections and impaired desquamation in certain inherited ichthyoses. JAMA Dermatol (2015) 0.86
The coordinated response of the physical and antimicrobial peptide barriers of the skin. J Invest Dermatol (2011) 0.86
Chemerin is an antimicrobial agent in human epidermis. PLoS One (2013) 0.86
Cholinergic regulation of keratinocyte innate immunity and permeability barrier integrity: new perspectives in epidermal immunity and disease. J Invest Dermatol (2011) 0.85
The roles of cutaneous lipids in host defense. Biochim Biophys Acta (2013) 0.85
Loss of Grainy head-like 1 is associated with disruption of the epidermal barrier and squamous cell carcinoma of the skin. PLoS One (2014) 0.85
Mechanisms of abnormal lamellar body secretion and the dysfunctional skin barrier in patients with atopic dermatitis. J Allergy Clin Immunol (2014) 0.85
Barrier-restoring therapies in atopic dermatitis: current approaches and future perspectives. Dermatol Res Pract (2012) 0.84
Novel Strategies in the Prevention and Treatment of Urinary Tract Infections. Pathogens (2016) 0.83
A topical Chinese herbal mixture improves epidermal permeability barrier function in normal murine skin. Exp Dermatol (2011) 0.83
Antimicrobial anxiety: the impact of stress on antimicrobial immunity. J Leukoc Biol (2010) 0.83
Lipid abnormalities and lipid-based repair strategies in atopic dermatitis. Biochim Biophys Acta (2013) 0.82
Resveratrol stimulates sphingosine-1-phosphate signaling of cathelicidin production. J Invest Dermatol (2013) 0.82
Pleiotropy as the Mechanism for Evolving Novelty: Same Signal, Different Result. Biology (Basel) (2015) 0.81
Abnormalities in stratum corneum function in patients recovered from leprosy. Skin Pharmacol Physiol (2009) 0.81
Epidermal barriers. Cold Spring Harb Perspect Med (2014) 0.81
Local Burn Injury Promotes Defects in the Epidermal Lipid and Antimicrobial Peptide Barriers in Human Autograft Skin and Burn Margin: Implications for Burn Wound Healing and Graft Survival. J Burn Care Res (2016) 0.80
The Ontogeny of Skin. Adv Wound Care (New Rochelle) (2014) 0.80
Nicotinic acetylcholine receptor stimulation impairs epidermal permeability barrier function and recovery and modulates cornified envelope proteins. Life Sci (2012) 0.79
An endoplasmic reticulum stress-initiated sphingolipid metabolite, ceramide-1-phosphate, regulates epithelial innate immunity by stimulating β-defensin production. Mol Cell Biol (2014) 0.79
Risk factor-dependent dynamics of atopic dermatitis: modelling multi-scale regulation of epithelium homeostasis. Interface Focus (2013) 0.78
Topical apigenin improves epidermal permeability barrier homoeostasis in normal murine skin by divergent mechanisms. Exp Dermatol (2013) 0.78
Topical hesperidin enhances epidermal function in an aged murine model. J Invest Dermatol (2014) 0.76
Atopic dermatitis and the stratum corneum: part 3: the immune system in atopic dermatitis. J Clin Aesthet Dermatol (2013) 0.76
Regulation of the Intestinal Barrier Function by Host Defense Peptides. Front Vet Sci (2015) 0.76
The Emergence of Physiology and Form: Natural Selection Revisited. Biology (Basel) (2016) 0.76
Novel perspectives on the role of the human microbiota in regenerative medicine and surgery. Biomed Rep (2016) 0.75
Sphingosine kinase 1 activation enhances epidermal innate immunity through sphingosine-1-phosphate stimulation of cathelicidin production. J Dermatol Sci (2015) 0.75
Nonspecific cytotoxic cell antimicrobial protein (NCAMP-1): a novel alarmin ligand identified in zebrafish. PLoS One (2015) 0.75
Current insights into the role of human β-defensins in atopic dermatitis. Clin Exp Immunol (2017) 0.75
Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med (2002) 9.01
Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature (2007) 7.17
Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods. Anal Biochem (2000) 6.74
Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature (2001) 6.71
Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem (1999) 6.54
The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc Natl Acad Sci U S A (1998) 3.83
The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J Biol Chem (1997) 3.82
Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J Clin Invest (1998) 3.51
Stratum corneum defensive functions: an integrated view. J Invest Dermatol (2005) 3.20
The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J Invest Dermatol (2003) 2.50
Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37. Biochemistry (2003) 2.48
Psychological stress perturbs epidermal permeability barrier homeostasis: implications for the pathogenesis of stress-associated skin disorders. Arch Dermatol (2001) 2.34
Dermcidin: a novel human antibiotic peptide secreted by sweat glands. Nat Immunol (2001) 2.29
Structural and lipid biochemical correlates of the epidermal permeability barrier. Adv Lipid Res (1991) 2.22
Genetic basis for increased intestinal permeability in families with Crohn's disease: role of CARD15 3020insC mutation? Gut (2005) 2.17
Human beta-defensin-2 production in keratinocytes is regulated by interleukin-1, bacteria, and the state of differentiation. J Invest Dermatol (2002) 2.17
Ionic calcium reservoirs in mammalian epidermis: ultrastructural localization by ion-capture cytochemistry. J Invest Dermatol (1985) 2.12
Epidermal lipids, barrier function, and desquamation. J Invest Dermatol (1983) 2.09
Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J Am Acad Dermatol (2002) 1.94
The permeability barrier in mammalian epidermis. J Cell Biol (1975) 1.94
UVB upregulates the antimicrobial protein hCAP18 mRNA in human skin. J Invest Dermatol (2005) 1.84
Vitamin D induces the antimicrobial protein hCAP18 in human skin. J Invest Dermatol (2005) 1.82
The skin barrier as an innate immune element. Semin Immunopathol (2007) 1.81
Resistin-like molecule beta regulates innate colonic function: barrier integrity and inflammation susceptibility. J Allergy Clin Immunol (2006) 1.79
High expression levels of keratinocyte antimicrobial proteins in psoriasis compared with atopic dermatitis. J Invest Dermatol (2005) 1.78
Membrane structures in normal and essential fatty acid-deficient stratum corneum: characterization by ruthenium tetroxide staining and x-ray diffraction. J Invest Dermatol (1991) 1.76
Biology and clinical relevance of naturally occurring antimicrobial peptides. J Allergy Clin Immunol (2002) 1.71
Transepidermal water loss: the signal for recovery of barrier structure and function. J Lipid Res (1989) 1.61
Antimicrobial skin peptides and proteins. Cell Mol Life Sci (2006) 1.56
Lipid content and lipid type as determinants of the epidermal permeability barrier. J Lipid Res (1989) 1.54
Keratinocytes store the antimicrobial peptide cathelicidin in lamellar bodies. J Invest Dermatol (2005) 1.48
Stress-induced changes in skin barrier function in healthy women. J Invest Dermatol (2001) 1.48
Cathelicidin anti-microbial peptide expression in sweat, an innate defense system for the skin. J Invest Dermatol (2002) 1.47
Differential regulation of beta-defensin expression in human skin by microbial stimuli. J Immunol (2005) 1.41
Barrier function regulates epidermal DNA synthesis. J Clin Invest (1991) 1.35
Epithelial antimicrobial peptides: innate local host response elements. Cell Mol Life Sci (1999) 1.35
The aged epidermal permeability barrier. Structural, functional, and lipid biochemical abnormalities in humans and a senescent murine model. J Clin Invest (1995) 1.33
In human epidermis, beta-defensin 2 is packaged in lamellar bodies. Exp Mol Pathol (2003) 1.33
Antimicrobial peptides. J Am Acad Dermatol (2005) 1.30
Interactions among stratum corneum defensive functions. Exp Dermatol (2005) 1.28
Lamellar body secretory response to barrier disruption. J Invest Dermatol (1992) 1.27
Psoriatic scales: a promising source for the isolation of human skin-derived antimicrobial proteins. J Leukoc Biol (2005) 1.26
Regulation of epidermal sphingolipid synthesis by permeability barrier function. J Lipid Res (1991) 1.24
Antimicrobial activity of sphingosines. J Invest Dermatol (1992) 1.24
Expression of natural peptide antibiotics in human skin. Lancet (1997) 1.22
The regulation and role of epidermal lipid synthesis. Adv Lipid Res (1991) 1.20
Retinoid effects on epidermal structure, differentiation, and permeability. Lab Invest (1981) 1.19
Lamellar body-enriched fractions from neonatal mice: preparative techniques and partial characterization. J Invest Dermatol (1985) 1.19
Antimicrobial peptides: an emerging concept in cutaneous biology. J Invest Dermatol (1998) 1.18
Stratum corneum structure and function correlates with phenotype in psoriasis. J Invest Dermatol (1996) 1.18
In vitro and in vivo antistaphylococcal activity of human stratum corneum lipids. Arch Dermatol (1988) 1.18
Immunology. Versatile defensins. Science (2002) 1.16
Protective roles of the skin against infection: implication of naturally occurring human antimicrobial agents beta-defensins, cathelicidin LL-37 and lysozyme. J Dermatol Sci (2005) 1.13
Functional consequences of a neutral pH in neonatal rat stratum corneum. J Invest Dermatol (2004) 1.09
Barrier function regulates epidermal lipid and DNA synthesis. Br J Dermatol (1993) 1.08
The secretory granular cell: the outermost granular cell as a specialized secretory cell. J Investig Dermatol Symp Proc (1998) 1.07
Basis for the permeability barrier abnormality in lamellar ichthyosis. Exp Dermatol (2002) 1.04
Permeability barrier requirements regulate epidermal beta-glucocerebrosidase. J Lipid Res (1994) 1.04
The lovastatin-treated rodent: a new model of barrier disruption and epidermal hyperplasia. J Invest Dermatol (1991) 1.03
Activators of the nuclear hormone receptors PPARalpha and FXR accelerate the development of the fetal epidermal permeability barrier. J Clin Invest (1997) 1.00
Coordinate assembly of lipids and enzyme proteins into epidermal lamellar bodies. Tissue Cell (1999) 1.00
Immunology. Unraveling gut inflammation. Science (2006) 0.98
Structural relationship between epidermal lipid lamellae, lamellar bodies and desmosomes in human epidermis: an ultrastructural study. Br J Dermatol (1993) 0.97
Sunlight, vitamin D, and the innate immune defenses of the human skin. J Invest Dermatol (2005) 0.96
Decreased IL-15 may contribute to elevated IgE and acute inflammation in atopic dermatitis. J Immunol (2002) 0.92
Cutaneous permeability barrier disruption increases fatty acid synthetic enzyme activity in the epidermis of hairless mice. J Invest Dermatol (1995) 0.88
Dynamic alteration of human beta-defensin 2 localization from cytoplasm to intercellular space in psoriatic skin. J Mol Med (Berl) (2002) 0.85
Characterization of nitric oxide production following isolation of rat hepatocytes. Toxicol Sci (2000) 0.83
In defense of skin. J Invest Dermatol (2005) 0.80
Isolation and purification of chemokines from natural sources. Mol Biotechnol (2001) 0.79
Epidermal vitamin D metabolism, function, and regulation. Adv Lipid Res (1991) 0.79
Isolation of lamellar bodies from neonatal mouse epidermis by selective sequential filtration. Science (1983) 0.77
A PCR method for the quantitative assessment of mRNA for laminin A, B1, and B2 chains. Kidney Int (1992) 0.77
Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science (2004) 19.19
Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science (2006) 18.74
The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab (2010) 13.29
IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest (2004) 11.05
Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med (2002) 9.01
Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood (2002) 7.58
Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet (2003) 5.82
The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat Med (2006) 5.20
High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat Med (2007) 5.18
Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc Natl Acad Sci U S A (2005) 5.05
Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res (2004) 4.67
Regulation of iron metabolism by hepcidin. Annu Rev Nutr (2006) 3.96
Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat Genet (2007) 3.94
Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J Clin Invest (2007) 3.82
HIF-1alpha expression regulates the bactericidal capacity of phagocytes. J Clin Invest (2005) 3.77
Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med (2007) 3.75
Hepcidin is decreased in TFR2 hemochromatosis. Blood (2004) 3.46
Defensins of vertebrate animals. Curr Opin Immunol (2002) 3.41
AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol (2009) 3.40
Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. Immunity (2006) 3.39
Commensal bacteria regulate Toll-like receptor 3-dependent inflammation after skin injury. Nat Med (2009) 3.32
Suppression of hepcidin during anemia requires erythropoietic activity. Blood (2006) 3.32
An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest (2003) 3.19
Lipopenia and skin barrier abnormalities in DGAT2-deficient mice. J Biol Chem (2003) 3.19
Thiazolidinedione use and bone loss in older diabetic adults. J Clin Endocrinol Metab (2006) 3.15
Paneth cell trypsin is the processing enzyme for human defensin-5. Nat Immunol (2002) 3.13
The molecular mechanism of hepcidin-mediated ferroportin down-regulation. Mol Biol Cell (2007) 2.99
Hepcidin in iron overload disorders. Blood (2005) 2.88
Recognition of hyaluronan released in sterile injury involves a unique receptor complex dependent on Toll-like receptor 4, CD44, and MD-2. J Biol Chem (2007) 2.82
Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J Biol Chem (2004) 2.81
IOM committee members respond to Endocrine Society vitamin D guideline. J Clin Endocrinol Metab (2012) 2.75
A homolog of Drosophila grainy head is essential for epidermal integrity in mice. Science (2005) 2.72
Systemic iron homeostasis. Physiol Rev (2013) 2.69
Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin. Blood (2005) 2.66
Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells. Blood (2009) 2.65
Hepcidin--a potential novel biomarker for iron status in chronic kidney disease. Clin J Am Soc Nephrol (2009) 2.61
Interleukin-6 regulates the zinc transporter Zip14 in liver and contributes to the hypozincemia of the acute-phase response. Proc Natl Acad Sci U S A (2005) 2.60
Adipocyte fatty acid-binding protein expression and lipid accumulation are increased during activation of murine macrophages by toll-like receptor agonists. Arterioscler Thromb Vasc Biol (2005) 2.56
Liver iron concentrations and urinary hepcidin in beta-thalassemia. Haematologica (2007) 2.52
Iron transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4. Blood (2007) 2.51
Histone acetylation in keratinocytes enables control of the expression of cathelicidin and CD14 by 1,25-dihydroxyvitamin D3. J Invest Dermatol (2007) 2.45
Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation. FASEB J (2006) 2.41
Diabetes-related complications, glycemic control, and falls in older adults. Diabetes Care (2007) 2.39
Neuroendocrine nicotinic receptor activation increases susceptibility to bacterial infections by suppressing antimicrobial peptide production. Cell Host Microbe (2010) 2.39
Administration of oral vitamin D induces cathelicidin production in atopic individuals. J Allergy Clin Immunol (2008) 2.33
Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin. FASEB J (2006) 2.33
Statins enhance formation of phagocyte extracellular traps. Cell Host Microbe (2010) 2.28
Liver X receptor activators display anti-inflammatory activity in irritant and allergic contact dermatitis models: liver-X-receptor-specific inhibition of inflammation and primary cytokine production. J Invest Dermatol (2003) 2.26
Urinary hepcidin excretion in patients with myelodysplastic syndrome and myelofibrosis. Br J Haematol (2008) 2.25
Retracted The hepcidin-binding site on ferroportin is evolutionarily conserved. Cell Metab (2008) 2.25
Mitotic recombination in patients with ichthyosis causes reversion of dominant mutations in KRT10. Science (2010) 2.21
Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum. J Allergy Clin Immunol (2009) 2.20
Anti-fungal activity of cathelicidins and their potential role in Candida albicans skin infection. J Invest Dermatol (2005) 2.19
Proinflammatory state, hepcidin, and anemia in older persons. Blood (2010) 2.19
Human beta-defensin-2 production in keratinocytes is regulated by interleukin-1, bacteria, and the state of differentiation. J Invest Dermatol (2002) 2.17
The antimicrobial protein REG3A regulates keratinocyte proliferation and differentiation after skin injury. Immunity (2012) 2.17
Coral bleaching--capacity for acclimatization and adaptation. Adv Mar Biol (2003) 2.17
Selective killing of vaccinia virus by LL-37: implications for eczema vaccinatum. J Immunol (2004) 2.16
Selective antimicrobial action is provided by phenol-soluble modulins derived from Staphylococcus epidermidis, a normal resident of the skin. J Invest Dermatol (2010) 2.13
The molecular basis of ferroportin-linked hemochromatosis. Proc Natl Acad Sci U S A (2005) 2.10
Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs. Blood (2005) 2.08
NOD2/CARD15 mediates induction of the antimicrobial peptide human beta-defensin-2. J Biol Chem (2005) 2.06
D-alanylation of teichoic acids promotes group a streptococcus antimicrobial peptide resistance, neutrophil survival, and epithelial cell invasion. J Bacteriol (2005) 2.04
In anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2. Blood (2010) 2.03
Interplay between antibacterial effectors: a macrophage antimicrobial peptide impairs intracellular Salmonella replication. Proc Natl Acad Sci U S A (2004) 2.00
Human defensin gene copy number polymorphisms: comprehensive analysis of independent variation in alpha- and beta-defensin regions at 8p22-p23. Genomics (2005) 1.97
Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J Am Acad Dermatol (2002) 1.94
Detection, evaluation, and management of iron-restricted erythropoiesis. Blood (2010) 1.93
NLRP3/cryopyrin is necessary for interleukin-1beta (IL-1beta) release in response to hyaluronan, an endogenous trigger of inflammation in response to injury. J Biol Chem (2009) 1.91
The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis. J Biol Chem (2002) 1.89
The role of hepcidin in iron metabolism. Acta Haematol (2009) 1.88
Cathelicidin deficiency predisposes to eczema herpeticum. J Allergy Clin Immunol (2006) 1.88
Control of the innate epithelial antimicrobial response is cell-type specific and dependent on relevant microenvironmental stimuli. Immunology (2006) 1.88
Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors. J Immunol (2003) 1.88
N-glycolylneuraminic acid deficiency in mice: implications for human biology and evolution. Mol Cell Biol (2007) 1.87
Loss of functional ELOVL4 depletes very long-chain fatty acids (> or =C28) and the unique omega-O-acylceramides in skin leading to neonatal death. Hum Mol Genet (2007) 1.87
Dermatan sulfate: new functions from an old glycosaminoglycan. Glycobiology (2002) 1.87
Cathelicidins: a family of endogenous antimicrobial peptides. Curr Opin Hematol (2002) 1.86
Cathelicidin mediates innate intestinal defense against colonization with epithelial adherent bacterial pathogens. J Immunol (2005) 1.86
Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons. J Exp Med (2010) 1.85
Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis: structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges. J Invest Dermatol (2007) 1.85
Antimicrobial peptides and the skin immune defense system. J Allergy Clin Immunol (2008) 1.85
Cutaneous defense mechanisms by antimicrobial peptides. J Invest Dermatol (2005) 1.85
Neutrophil-derived cathelicidin protects from neointimal hyperplasia. Sci Transl Med (2011) 1.84
Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in mice. Hepatology (2011) 1.82
Activation of Toll-like receptor 2 on human tracheobronchial epithelial cells induces the antimicrobial peptide human beta defensin-2. J Immunol (2003) 1.82
Neutrophil-derived cathelicidin promotes adhesion of classical monocytes. Circ Res (2013) 1.80
The 2011 Dietary Reference Intakes for Calcium and Vitamin D: what dietetics practitioners need to know. J Am Diet Assoc (2011) 1.80
M1 protein allows Group A streptococcal survival in phagocyte extracellular traps through cathelicidin inhibition. J Innate Immun (2009) 1.80
Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J Immunol (2003) 1.79
Activation of TLR2 by a small molecule produced by Staphylococcus epidermidis increases antimicrobial defense against bacterial skin infections. J Invest Dermatol (2010) 1.79
The neuroendocrine peptide catestatin is a cutaneous antimicrobial and induced in the skin after injury. J Invest Dermatol (2008) 1.79